Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Lipids as promising BRidge between novel disease InsiGHts and improved Therapy

Project description

Lipid biology for diagnostics and therapy

Lipids play a key role in diseases like cancer, cardiovascular disease, kidney disease, and chronic inflammation. Studying lipids could lead to new treatments. As such, researchers are taking a closer look at lipid metabolism in diseases with the aim of developing tools for detecting and imaging lipids. Supported by the Marie Skłodowska-Curie Actions programme, the LipiBRIGHT project aims to train young researchers in lipid biology, new technologies, and clinical applications. Forming a group of leading institutes, small and medium-sized enterprises, and industry partners, doctoral students will investigate lipid biomarkers, disease mechanisms, and clinical uses. The project’s overarching goal is to speed up the application of lipid research into new diagnostics and therapies.

Objective

Recent insights revealed new, decisive roles for lipids in cardiovascular disease, chronic kidney disease, cancer and chronic inflammation. Lipid targeting may offer novel treatment opportunities for these four high-impact diseases, complementary to the currently available, insufficiently effective therapies. However, developing effective diagnostic, preventive and therapeutic solutions requires deeper insights into lipid metabolism in disease as well as improved methods of lipid detection and imaging. Furthermore, an increasing interest in lipids in clinical applications, demonstrated by our associated partners, generates job profiles requiring novel, lipid-focused, interdisciplinary training. LipidBRIGHT is the first lipid-focused ITN designed to address the unmet medical need to i) better understand lipid metabolism in disease and ii) train young scientists in the emerging lipids field, associated technologies and clinical applications, this to speed-up understanding of lipid-associated diseases and translation into novel strategies for disease diagnosis, prevention and treatment.

LipidBRIGHT comprises 6 forefront-running, interdisciplinary and intersectoral research institutes and 2 SMEs with complementary expertise in lipid-associated diseases, technology and translation, supported by 4 academic and 1 international research institute, 3 SMEs, 4 international companies, 2 stakeholder-representing organisations and 1 international organisation of mixed academic/private members. With established cooperations, we will train doctoral students around three pillars: (i) Lipid biomarkers, artificial intelligence and disease modelling, (ii) Lipid-associated pathology & disease mechanisms, and (iii) Lipid application in clinics & industry. This will provide excellent scientific, technological and transferable skills to generate innovative insights in the opportunities of lipid research, and boost EU competitiveness in lipid research, translation and application.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral Networks

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-DN-01

See all projects funded under this call

Coordinator

UNIVERSITEIT MAASTRICHT
Net EU contribution
€ 890 416,80
Address
MINDERBROEDERSBERG 4
6200 MD Maastricht
Netherlands
Region
Zuid-Nederland Limburg (NL) Zuid-Limburg
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Participants (8)

Partners (17)